VIII Symposium "Design, Obtaining and Development of Drugs" "SICF"

VIII International Symposium on Chemistry and Pharmaceutical Sciences

SICF

VIII Symposium "Design, Obtaining and Development of Drugs"

actividad antitumoral. × interleukin-2 (il-2) mutant ×

Book your talks

Plan your experience by adding your favorites talks to your wishlist

Tuesday 14
November 2023

PEGylation strategy for improving the pharmacokinetic activity of the IL-2 no-alpha mutein.
Marianniz Díaz Hernández

actividad antitumoral. antitumor activity. farmacocinética interleukin-2 (il-2) mutant mutante de interleucina-2 (il-2) pegilación pegylation pharmacokinetic

Instituto Finlay de Vaunas

EAA Heriberto Duquesne

Gold

Álamo Empresa Cárnica

Silver

BIOCUBAFARMA

Centro de Análisis del Ciclo de Vida (CADIS)